Harrow (HROW) Revenue (2013 - 2026)
Harrow's (HROW) quarterly Revenue came in at $44.2 million in Q1 2026, down 7.59% year-on-year from $47.8 million in Q1 2025, and down 50.38% quarter-over-quarter from $89.1 million in Q4 2025.
Harrow (HROW) Revenue (2013 - 2026) Analysis & Trends
Harrow's Revenue history runs 14 years deep, the most recent figure standing at $44.2 million for Q1 2026.
- On a quarterly basis, Revenue fell 7.59% year-over-year to $44.2 million in Q1 2026; TTM through Mar 2026 was $268.7 million, a 26.22% increase from a year earlier, with the FY2025 full-year figure at $272.3 million, up 36.41% from the prior year.
- Revenue eased to $44.2 million in Q1 2026 per HROW's latest filing, from $89.1 million in the prior quarter.
- Across five years, Revenue topped out at $89.1 million in Q4 2025 and bottomed at $20.3 million in Q4 2022.
- The 5-year median for Revenue is $36.4 million (2023), against an average of $43.2 million.
- Across the five-year window, Revenue surged 83.83% in 2024 and slipped 7.59% in 2026, its largest moves.
- Year by year, Revenue stood at $20.3 million in 2022, then soared by 78.83% to $36.4 million in 2023, then jumped by 83.83% to $66.8 million in 2024, then soared by 33.31% to $89.1 million in 2025, then plunged by 50.38% to $44.2 million in 2026.
- Per Business Quant, the three latest HROW Revenue figures stand at $44.2 million (Q1 2026), $89.1 million (Q4 2025), and $71.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 781.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.37 Bn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn | 44.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.20 Mn |
| Dec 31, 2025 | 89.09 Mn |
| Sep 30, 2025 | 71.64 Mn |
| Jun 30, 2025 | 63.74 Mn |
| Mar 31, 2025 | 47.83 Mn |
| Dec 31, 2024 | 66.83 Mn |
| Sep 30, 2024 | 49.26 Mn |
| Jun 30, 2024 | 48.94 Mn |
| Mar 31, 2024 | 34.59 Mn |
| Dec 31, 2023 | 36.36 Mn |
| Sep 30, 2023 | 34.27 Mn |
| Jun 30, 2023 | 33.47 Mn |
| Mar 31, 2023 | 26.10 Mn |
| Dec 31, 2022 | 20.33 Mn |
| Sep 30, 2022 | 22.82 Mn |
| Jun 30, 2022 | 23.32 Mn |
| Mar 31, 2022 | 22.12 Mn |
| Dec 31, 2021 | 20.19 Mn |
| Sep 30, 2021 | 18.71 Mn |
| Jun 30, 2021 | 18.13 Mn |